Business Context and Reporting Period
Company: Intelligent Bio Solutions Inc. (INBS)
Filing Type: Form 8-K (Current Report)
Date of Report: December 14, 2022
Reporting Period: Single event date (December 14, 2022)
Context: The filing serves as a Regulation FD disclosure to make a business presentation available to investors. The company is an emerging growth company incorporated in Delaware.
Key Financial Metrics
The filing text does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity figures. This document is a procedural filing to announce the availability of a presentation rather than a financial statement.
Material Changes
No material changes to financial performance or operations are detailed within the text of this filing. The primary event is the release of a presentation regarding the company's business and operations.
Guidance, Outlook, and Risks
Management Commentary: The company furnished a presentation (Exhibit 99.1) available on its investor website (www.gbs.inc) relating to its business and operations.
Legal Disclaimer: The information furnished under Item 7.01, including the presentation, is not deemed "filed" under Section 18 of the Exchange Act and is not subject to the liability of that section. It shall not be incorporated by reference into any other company filings.
Investor Verification Checklist
- Verify the content of the presentation (Exhibit 99.1) on the company's investor website for specific operational updates.
- Confirm the company's status as an emerging growth company and its implications for financial reporting standards.
- Note that this 8-K does not contain audited financial results; refer to the most recent 10-K or 10-Q for quantitative data.
- Check the Nasdaq Stock Market listing status for the common stock (Symbol: INBS).